PM

Prajkta Milind Kulkarni

Active Director Designated Partner DIN 08662342
DIN 08662342 First appointment Jan 2020 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Prajkta Milind Kulkarni

Data last updated:

Prajkta Milind Kulkarni is a Designated Partner at Medidec Pharma Llp (since 2020). The company operates in Chemicals.

DIN 08662342
Primary Designation Designated Partner
Industry Chemicals
First Appointment 08 Jan 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner08 Jan 20202020Active

Board colleagues of Prajkta Milind Kulkarni

NameDINCompanyDesignation
Archana Swapnil Shah00390609Medidec Pharma LlpDesignated Partner
Milind Madhukar Kulkarni08662341Medidec Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Medidec Pharma Llp
Premium access

Shareholding and investment profile for Prajkta Milind Kulkarni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prajkta Milind Kulkarni

Prajkta Milind Kulkarni currently holds 1 directorship: Medidec Pharma Llp (Designated Partner, since 08 Jan 2020).

Prajkta Milind Kulkarni was first appointed on 08 Jan 2020 as Designated Partner at Medidec Pharma Llp.

The current boards of Prajkta Milind Kulkarni's companies include Archana Swapnil Shah (Medidec Pharma Llp), Milind Madhukar Kulkarni (Medidec Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available